TGF beta receptor 2

Protein-coding gene in the species Homo sapiens
TGFBR2
Available structures
PDBOrtholog search: PDBe RCSB
List of PDB id codes

1KTZ, 1M9Z, 1PLO, 2PJY, 3KFD, 4P7U, 4XJJ, 5E92, 5E91, 5E8V, 5E8Y

Identifiers
AliasesTGFBR2, AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2, RIIC, TAAD2, TGFR-2, TGFbeta-RII, transforming growth factor beta receptor 2, TBR-ii, TBRII
External IDsOMIM: 190182 MGI: 98729 HomoloGene: 2435 GeneCards: TGFBR2
Gene location (Human)
Chromosome 3 (human)
Chr.Chromosome 3 (human)[1]
Chromosome 3 (human)
Genomic location for TGFBR2
Genomic location for TGFBR2
Band3p24.1Start30,606,601 bp[1]
End30,694,142 bp[1]
Gene location (Mouse)
Chromosome 9 (mouse)
Chr.Chromosome 9 (mouse)[2]
Chromosome 9 (mouse)
Genomic location for TGFBR2
Genomic location for TGFBR2
Band9 F3|9 68.39 cMStart115,913,361 bp[2]
End116,004,428 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • pericardium

  • tibia

  • parietal pleura

  • lower lobe of lung

  • visceral pleura

  • vena cava

  • superficial temporal artery

  • synovial joint

  • subcutaneous adipose tissue

  • cardia
Top expressed in
  • left lung lobe

  • calvaria

  • lymph node

  • sciatic nerve

  • molar

  • right lung

  • stria vascularis

  • uterus

  • cervix

  • right lung lobe
More reference expression data
BioGPS


More reference expression data
Gene ontology
Molecular function
  • transforming growth factor beta-activated receptor activity
  • kinase activity
  • ATP binding
  • type III transforming growth factor beta receptor binding
  • protein kinase activity
  • transforming growth factor beta receptor activity, type II
  • metal ion binding
  • protein serine/threonine kinase activity
  • transferase activity
  • type I transforming growth factor beta receptor binding
  • mitogen-activated protein kinase kinase kinase binding
  • protein binding
  • SMAD binding
  • nucleotide binding
  • glycosaminoglycan binding
  • transforming growth factor beta binding
  • transmembrane receptor protein serine/threonine kinase activity
  • signaling receptor activity
  • growth factor binding
Cellular component
  • cytoplasm
  • cytosol
  • membrane
  • caveola
  • cell surface
  • membrane raft
  • integral component of membrane
  • receptor complex
  • plasma membrane
  • integral component of plasma membrane
  • external side of plasma membrane
Biological process
  • growth plate cartilage development
  • response to cholesterol
  • lens fiber cell apoptotic process
  • response to steroid hormone
  • positive regulation of T cell tolerance induction
  • receptor-mediated endocytosis
  • response to organic substance
  • vasculogenesis
  • protein phosphorylation
  • positive regulation of B cell tolerance induction
  • positive regulation of reactive oxygen species metabolic process
  • blood vessel development
  • positive regulation of mesenchymal cell proliferation
  • animal organ regeneration
  • animal organ morphogenesis
  • transforming growth factor beta receptor signaling pathway
  • embryo implantation
  • negative regulation of cell population proliferation
  • apoptotic process
  • pathway-restricted SMAD protein phosphorylation
  • common-partner SMAD protein phosphorylation
  • bronchus morphogenesis
  • lung development
  • response to mechanical stimulus
  • positive regulation of epithelial cell migration
  • in utero embryonic development
  • negative regulation of transforming growth factor beta receptor signaling pathway
  • heart development
  • cartilage development
  • positive regulation of tolerance induction to self antigen
  • branching involved in blood vessel morphogenesis
  • positive regulation of skeletal muscle tissue regeneration
  • smoothened signaling pathway
  • negative regulation of cardiac muscle cell proliferation
  • Notch signaling pathway
  • cell differentiation
  • phosphorylation
  • response to nutrient
  • mammary gland morphogenesis
  • wound healing
  • response to glucose
  • positive regulation of epithelial to mesenchymal transition
  • positive regulation of angiogenesis
  • response to estrogen
  • gastrulation
  • regulation of gene expression
  • embryonic cranial skeleton morphogenesis
  • peptidyl-threonine phosphorylation
  • trachea formation
  • lung lobe morphogenesis
  • positive regulation of smooth muscle cell proliferation
  • lung morphogenesis
  • response to organic cyclic compound
  • trachea morphogenesis
  • human ageing
  • myeloid dendritic cell differentiation
  • bronchus development
  • brain development
  • transmembrane receptor protein serine/threonine kinase signaling pathway
  • lens development in camera-type eye
  • regulation of cell population proliferation
  • peptidyl-serine phosphorylation
  • positive regulation of cell population proliferation
  • embryonic hemopoiesis
  • growth plate cartilage chondrocyte growth
  • regulation of growth
  • positive regulation of NK T cell differentiation
  • digestive tract development
  • activation of protein kinase activity
  • response to hypoxia
  • heart looping
  • outflow tract septum morphogenesis
  • membranous septum morphogenesis
  • outflow tract morphogenesis
  • atrioventricular valve morphogenesis
  • tricuspid valve morphogenesis
  • cardiac left ventricle morphogenesis
  • endocardial cushion fusion
  • ventricular septum morphogenesis
  • positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation
  • cell proliferation involved in endocardial cushion morphogenesis
  • positive regulation of CD4-positive, alpha-beta T cell proliferation
  • superior endocardial cushion morphogenesis
  • inferior endocardial cushion morphogenesis
  • miRNA transport
  • secondary palate development
  • pattern specification process
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

7048

21813

Ensembl

ENSG00000163513

ENSMUSG00000032440

UniProt

P37173

Q62312

RefSeq (mRNA)

NM_001024847
NM_003242

NM_009371
NM_029575

RefSeq (protein)

NP_001020018
NP_003233

NP_033397
NP_083851

Location (UCSC)Chr 3: 30.61 – 30.69 MbChr 9: 115.91 – 116 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Transforming growth factor, beta receptor II (70/80kDa) is a TGF beta receptor. TGFBR2 is its human gene.

It is a tumor suppressor gene.[5]

Function

This gene encodes a member of the serine/threonine protein kinase family and the TGFB receptor subfamily. The encoded protein is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with another receptor protein, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of a subset of genes related to cell proliferation. Mutations in this gene have been associated with Marfan syndrome, Loeys-Deitz aortic aneurysm syndrome, Osler–Weber–Rendu syndrome, and the development of various types of tumors. At least 73 disease-causing mutations in this gene have been discovered.[6] Alternatively spliced transcript variants encoding different isoforms have been characterized.[7]

Interactions

TGF beta receptor 2 has been shown to interact with:

Domain architecture

Transforming growth factor beta receptor 2 ectodomain
crystal structure of human tgf-beta type ii receptor ligand binding domain
Identifiers
SymbolecTbetaR2
PfamPF08917
InterProIPR015013
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

TGF beta receptor 2 consists of a C-terminal protein kinase domain and an N-terminal ectodomain. The ectodomain consists of a compact fold containing nine beta-strands and a single helix stabilised by a network of six intra strand disulphide bonds. The folding topology includes a central five-stranded antiparallel beta-sheet, eight-residues long at its centre, covered by a second layer consisting of two segments of two-stranded antiparallel beta-sheets (beta1-beta4, beta3-beta9).[18]

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000163513 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000032440 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "TGFBR2 - transforming growth factor, beta receptor II (70/80kDa) - Genetics Home Reference". Archived from the original on 2011-08-10. Retrieved 2008-09-07.
  6. ^ Šimčíková D, Heneberg P (December 2019). "Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases". Scientific Reports. 9 (1): 18577. Bibcode:2019NatSR...918577S. doi:10.1038/s41598-019-54976-4. PMC 6901466. PMID 31819097.
  7. ^ "Entrez Gene: TGFBR2 transforming growth factor, beta receptor II (70/80kDa)".
  8. ^ Yao D, Ehrlich M, Henis YI, Leof EB (Nov 2002). "Transforming growth factor-beta receptors interact with AP2 by direct binding to beta2 subunit". Molecular Biology of the Cell. 13 (11): 4001–12. doi:10.1091/mbc.02-07-0104. PMC 133610. PMID 12429842.
  9. ^ Liu JH, Wei S, Burnette PK, Gamero AM, Hutton M, Djeu JY (Jan 1999). "Functional association of TGF-beta receptor II with cyclin B". Oncogene. 18 (1): 269–75. doi:10.1038/sj.onc.1202263. PMID 9926943.
  10. ^ a b Barbara NP, Wrana JL, Letarte M (Jan 1999). "Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily". The Journal of Biological Chemistry. 274 (2): 584–94. doi:10.1074/jbc.274.2.584. PMID 9872992.
  11. ^ Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C (Aug 2002). "Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II". The Journal of Biological Chemistry. 277 (32): 29197–209. doi:10.1074/jbc.M111991200. hdl:10261/167807. PMID 12015308.
  12. ^ Wrighton KH, Lin X, Feng XH (Jul 2008). "Critical regulation of TGFbeta signaling by Hsp90". Proceedings of the National Academy of Sciences of the United States of America. 105 (27): 9244–9. Bibcode:2008PNAS..105.9244W. doi:10.1073/pnas.0800163105. PMC 2453700. PMID 18591668.
  13. ^ Datta PK, Chytil A, Gorska AE, Moses HL (Dec 1998). "Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling". The Journal of Biological Chemistry. 273 (52): 34671–4. doi:10.1074/jbc.273.52.34671. PMID 9856985.
  14. ^ Datta PK, Moses HL (May 2000). "STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling". Molecular and Cellular Biology. 20 (9): 3157–67. doi:10.1128/mcb.20.9.3157-3167.2000. PMC 85610. PMID 10757800.
  15. ^ Kawabata M, Chytil A, Moses HL (Mar 1995). "Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor". The Journal of Biological Chemistry. 270 (10): 5625–30. doi:10.1074/jbc.270.10.5625. PMID 7890683.
  16. ^ Razani B, Zhang XL, Bitzer M, von Gersdorff G, Böttinger EP, Lisanti MP (Mar 2001). "Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor". The Journal of Biological Chemistry. 276 (9): 6727–38. doi:10.1074/jbc.M008340200. PMID 11102446.
  17. ^ De Crescenzo G, Pham PL, Durocher Y, O'Connor-McCourt MD (May 2003). "Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding". Journal of Molecular Biology. 328 (5): 1173–83. doi:10.1016/s0022-2836(03)00360-7. PMID 12729750.
  18. ^ a b Hart PJ, Deep S, Taylor AB, Shu Z, Hinck CS, Hinck AP (Mar 2002). "Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex". Nature Structural Biology. 9 (3): 203–8. doi:10.1038/nsb766. PMID 11850637. S2CID 13322593.
  19. ^ Rotzer D, Roth M, Lutz M, Lindemann D, Sebald W, Knaus P (Feb 2001). "Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor". The EMBO Journal. 20 (3): 480–90. doi:10.1093/emboj/20.3.480. PMC 133482. PMID 11157754.

External links

  • GeneReviews/NIH/NCBI/UW entry on Thoracic Aortic Aneurysms and Aortic Dissections
  • v
  • t
  • e
  • 1ktz: Crystal Structure of the Human TGF-beta Type II Receptor Extracellular Domain in Complex with TGF-beta3
    1ktz: Crystal Structure of the Human TGF-beta Type II Receptor Extracellular Domain in Complex with TGF-beta3
  • 1m9z: CRYSTAL STRUCTURE OF HUMAN TGF-BETA TYPE II RECEPTOR LIGAND BINDING DOMAIN
    1m9z: CRYSTAL STRUCTURE OF HUMAN TGF-BETA TYPE II RECEPTOR LIGAND BINDING DOMAIN
  • 1plo: TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN
    1plo: TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN
  • v
  • t
  • e
Chemokine receptor
(GPCRs)
CC
CXC
Other
TNF receptor
1-10
11-20
21-27
JAK-STAT
Type I
γ-chain
β-chain
gp130
IL12RB1
Other
Type II
Ig superfamily
IL 17 family
Enzyme-linked receptor
  • v
  • t
  • e
TGFβ receptor superfamily modulators
Type I
ALK1 (ACVRL1)
  • Kinase inhibitors: K-02288
  • ML-347 (LDN-193719, VU0469381)
  • Other inhibitors: Disitertide
ALK2 (ACVR1A)
  • Kinase inhibitors: DMH-1
  • DMH-2
  • Dorsomorphin (BML-275)
  • K-02288
  • ML-347 (LDN-193719, VU0469381)
ALK3 (BMPR1A)
  • Kinase inhibitors: DMH-2
  • Dorsomorphin (BML-275)
  • K-02288
ALK4 (ACVR1B)
  • Kinase inhibitors: A 83-01
  • SB-431542
  • SB-505124
ALK5 (TGFβR1)
ALK6 (BMPR1B)
  • Kinase inhibitors: DMH-2
  • Dorsomorphin (BML-275)
  • K-02288
ALK7 (ACVR1C)
  • Antagonists: Lefty (1, 2)
  • Kinase inhibitors: A 83-01
  • SB-431542
  • SB-505124
Type II
TGFβR2
  • Kinase inhibitors: DMH-2
  • LY-364947
BMPR2
ACVR2A (ACVR2)
ACVR2B
  • Decoy receptors: Ramatercept
AMHR2 (AMHR)
Type III
TGFβR3 (β-glycan)
Unsorted
  • v
  • t
  • e
Ligand
Growth factors
ONCO
Receptor
Wnt signaling pathway
TSP
  • CDH1
Hedgehog signaling pathway
TSP
TGF beta signaling pathway
TSP
  • TGF beta receptor 2
Receptor tyrosine kinase
ONCO
JAK-STAT signaling pathway
ONCO
Intracellular signaling P+Ps
Wnt signaling pathway
ONCO
TSP
TGF beta signaling pathway
TSP
Akt/PKB signaling pathway
ONCO
TSP
  • PTEN
Hippo signaling pathway
TSP
  • Neurofibromin 2/Merlin
MAPK/ERK pathway
ONCO
TSP
Other/unknown
ONCO
TSP
Nucleus
Cell cycle
ONCO
TSP
DNA repair/Fanconi
TSP
Ubiquitin ligase
ONCO
TSP
Transcription factor
ONCO
TSP
Mitochondrion
Apoptosis inhibitor
Other/ungrouped
This article incorporates text from the public domain Pfam and InterPro: IPR015013